Antioxidant pharmacological therapies for COPD.
Antioxidant pharmacological therapies for COPD.
复制标题
DOI:
10.1016/j.coph.2012.01.015
复制
发表时间:
2012-06
影响因子:
4
通讯作者:
MacNee, William
中科院分区:
文献类型:
--
作者:
Rahman, Irfan;MacNee, William
Increased oxidative stress occurs in the lungs and systemically in COPD, which plays a role in many of the pathogenic mechanisms in COPD. Hence, targeting local lung and systemic oxidative stress with agents that modulate the antioxidants/redox system or boost endogenous antioxidants would be a useful therapeutic approach in COPD. Thiol antioxidants (N-acetyl-L-cysteine and N-acystelyn, carbocysteine, erdosteine, and fudosteine have been used to increase lung thiol content. Modulation of cigarette smoke induced oxidative stress and its consequent cellular changes have also been reported to be effected by synthetic molecules, such as spin traps (α-phenyl-N-tert-butyl nitrone), catalytic antioxidants (superoxide dismutase [ECSOD] mimetics), porphyrins, and lipid peroxidation and protein carbonylation blockers/inhibitors (edaravone and lazaroids/tirilazad). Pre-clinical and clinical trials have shown that these antioxidants can reduce oxidative stress, affect redox and glutathione biosynthesis genes, and pro-inflammatory gene expression. In this review the approaches to enhance lung antioxidants in COPD and the potential beneficial effects of antioxidant therapy on the course of the disease are discussed.
登录
查看更多内容
影响因子:
3.1
作者:
Black PN;Morgan-Day A;McMillan TE;Poole PJ;Young RP
通讯作者:
Young RP
影响因子:
3.9
作者:
Day, BJ;Fridovich, I;Crapo, JD
通讯作者:
Crapo, JD
影响因子:
7.4
作者:
Bachnoff, Niv;Trus, Michael;Atlas, Daphne
通讯作者:
Atlas, Daphne
影响因子:
4.8
作者:
Ferrer-Sueta, G;Vitturi, D;Radi, R
通讯作者:
Radi, R
DOI:
10.1124/jpet.104.074153
发表时间:
2005-02-01
影响因子:
3.5
作者:
Foresti, R;Hoque, M;Motterlini, R
通讯作者:
Motterlini, R